Randomized Assessment of Rapid Endovascular Treatment in Basilar Artery Occlusion Stroke in 115 Hospital
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Stroke, Acute
- Sponsor
- University of Medicine and Pharmacy at Ho Chi Minh City
- Enrollment
- 109
- Primary Endpoint
- Survival rate in patients with Basilar Artery Occlusion Stroke
- Last Updated
- 6 years ago
Overview
Brief Summary
This is a prospective, open lable studies conducted in 115 hospital to compare between thromboectomy and Recombinant Tisue Plasminogen Activator only to evaluate the eficacy and safety of endovascular treatment in basilar artery occlusion stroke patients
Detailed Description
Acute basilar artery thrombosis is associated with a poor prognosis. Prevalence of basilar artery occlusion are not known. Although basilar artery occlusion has been reported in 2 per 1000 autopsy cases, basilar artery thrombosis may, in stroke registries, explain as many as 27% of ischemic strokes occurring in the posterior circulation.Various treatments were tried in groups of patients with vertebrobasilar territory infarction but evidence based was not cleared previous studies. Therefore, we conduct this study to evaluate the eficacy and safety of endovascular treatment in basilar artery occlusion stroke patients
Investigators
Tran Nguyen Uyen Dung
Randomized Assessment of Rapid Endovascular Treatment in Basilar Artery occlusion stroke in 115 hospital
University of Medicine and Pharmacy at Ho Chi Minh City
Eligibility Criteria
Inclusion Criteria
- •Patients admit to 115 hospital in 24h of Basilar Artery Occlusion Stroke
- •NIHSS \> 4 points
Exclusion Criteria
- •Patients refuse to participate in studies
- •Patients with contraindication of either rTPA or thromboectomy
Outcomes
Primary Outcomes
Survival rate in patients with Basilar Artery Occlusion Stroke
Time Frame: 3 months from admission
Survival rate in patients with Basilar Artery Occlusion Stroke
NIHSS in patients wtih Basilar Artery Occlusion Stroke after 24hour admission
Time Frame: 24 hours from admission
NIHSS in patients wtih Basilar Artery Occlusion Stroke after 24hour admission
Secondary Outcomes
- mRS in patients with Basilar Artery Occlusion Stroke(3 months from admission)